###begin article-title 0
###xml 71 76 <span type="species:ncbi:4932">yeast</span>
Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 411 435 411 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis in vitro</italic>
###xml 411 426 <span type="species:ncbi:5480">C. parapsilosis</span>
Mannose binding lectin (MBL) is an important host defence protein against opportunistic fungal pathogens. This carbohydrate-binding protein, an opsonin and lectin pathway activator, binds through multiple lectin domains to the repeating sugar arrays displayed on the surface of a wide range of clinically relevant microbial species. We investigated the contribution of MBL to antifungal innate immunity towards C. parapsilosis in vitro.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 50 62 50 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 66 81 66 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis</italic>
###xml 188 199 188 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 201 217 201 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 231 245 231 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 322 338 322 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 340 362 340 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 366 389 366 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans</italic>
###xml 391 407 391 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 411 428 411 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 50 61 <span type="species:ncbi:5476">C. albicans</span>
###xml 66 81 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 188 199 <span type="species:ncbi:5476">C. albicans</span>
###xml 201 216 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 231 244 <span type="species:ncbi:5207">C. neoformans</span>
###xml 322 338 <span type="species:ncbi:562">Escherichia coli</span>
###xml 340 361 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 366 378 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 366 389 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 391 406 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 411 427 <span type="species:ncbi:5476">Candida albicans</span>
High avidity binding was observed between MBL and C. albicans and C. parapsilosis. Addition of MBL to MBL deficient serum increased the deposition of C4 and C3b and enhanced the uptake of C. albicans, C. parapsilosis and acapsular C. neoformans by polymorphonuclear cells (PMNs). Compared to other microorganisms, such as Escherichia coli, Staphylococcus aureus and Cryptococcus neoformans, C. parapsilosis and Candida albicans were potent activators of the lectin pathway.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 102 107 <span type="species:ncbi:4932">yeast</span>
Our results suggest that MBL plays a crucial role in the innate immunity against infections caused by yeast by increasing uptake by PMN.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Mannose binding lectin [1], a plasma protein of hepatic origin that belongs to the family of calcium-dependent collagenous lectins (collectin), is an important protein of the innate immune system [1-6]. This carbohydrate-binding protein binds mannose and N-acetylglucosamine (GlcNAc) sugars and their derivates present on the surface of a wide range of clinically relevant microbial species and has the ability to distinguish self from nonself [4,5,7,8].
###end p 9
###begin p 10
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 692 693 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
MBL initiates the lectin pathway of complement using attached mannose binding lectin-associated serine proteases (MASP-2) in an antibody- and C1q-independent manner [5,7,9]. MASP-2 is indistinguishable in specificity from the convertases found in the classical and alternative of complement activation and permits cleavage of C4 and C2 to form a C3 convertase [3,5,7,10]. Once it has bound, MBL is able to deploy a variety of anti-microbial activities, such as microbial opsonization and/or microbial lysis via membrane attack complexes [8,11]. However, it is unclear whether MBL acts as a direct opsonin or is merely enhances other complement pathways and/or antibody-mediated phagocytosis [5].
###end p 10
###begin p 11
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
MBL deficiency, due to variation in the MBL gene, is one of the most common immunodeficiencies [5,12] and is associated with impaired phagocytosis by polymorphonuclear leukocytes and with an increased burden of infections, especially in immunocompromised individuals [13-15].
###end p 11
###begin p 12
###xml 52 68 52 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 149 161 149 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 510 522 510 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 586 587 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 660 662 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 663 665 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 52 67 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 149 160 <span type="species:ncbi:5476">C. albicans</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 386 394 <span type="species:ncbi:9606">patients</span>
###xml 510 521 <span type="species:ncbi:5476">C. albicans</span>
The clinically relevant opportunistic microorganism C. parapsilosis is now the second or third most common cause of systemic fungal infections after C. albicans [16-19]. It is especially prevalent in very low birth weight neonates, transplant patients, post-surgical patients, patients receiving intravenous hyperalimentation and patients with indwelling invasive devices [20-23]. Most patients at risk have some degree of immunosuppression. MBL has been shown to play a role in the first-line defence against C. albicans [9]. The fungal cell wall, which consists mainly of polymers of N-acetylglucosamine (chitin), glucose (beta-glucan) and mannose (mannan) [15,24] is a candidate ligand for MBL and may be capable of activating the lectin complement pathway.
###end p 12
###begin p 13
###xml 72 87 72 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis</italic>
###xml 155 170 155 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis</italic>
###xml 172 184 172 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 198 211 198 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 72 87 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 155 170 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 172 183 <span type="species:ncbi:5476">C. albicans</span>
###xml 198 211 <span type="species:ncbi:5207">C. neoformans</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
In this study we evaluated the role of MBL in the opsonophagocytosis of C. parapsilosis. MBL was found to be a crucial opsonin for optimal phagocytosis of C. parapsilosis, C. albicans and acapsular C. neoformans. Sera of patients with MBL deficiency have decreased opsonic capacity.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Microbial strains
###end title 15
###begin p 16
###xml 22 43 22 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida parapsilosis </italic>
###xml 131 148 131 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 236 260 236 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 346 359 346 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 413 435 413 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 498 508 498 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 584 601 584 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 616 624 616 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 694 719 694 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 22 42 <span type="species:ncbi:5480">Candida parapsilosis</span>
###xml 131 147 <span type="species:ncbi:5476">Candida albicans</span>
###xml 236 248 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 236 259 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 346 359 <span type="species:ncbi:5207">C. neoformans</span>
###xml 413 434 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 498 507 <span type="species:ncbi:1280">S. aureus</span>
###xml 584 600 <span type="species:ncbi:562">Escherichia coli</span>
###xml 616 623 <span type="species:ncbi:562">E. coli</span>
###xml 694 718 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 863 868 <span type="species:ncbi:4932">yeast</span>
A clinical isolate of Candida parapsilosis strain 05-173 (California Institute for Medical Research, San Jose, CA), as a reference Candida albicans strain ATCC 14053 (American Type Culture Collection), the thinly (<0.5 mm) encapsulated Cryptococcus neoformans strain NIH 37 (National Institute of Health, Bethesda, MD) and an acapsular mutant of C. neoformans, CAP 67 (E.S. Jacobson, Medical College of Virginia) Staphylococcus aureus Mu 50 (Japanese Collection of Staphylococcus Cultures (JCSC)), S. aureus KV 39 and KV 68 (clinical isolates from University Medical Centre Utrecht), Escherichia coli ATCC 25922 and E. coli ATCC 35218 (American Type Culture Collection) were used. In addition, Saccharomyces cerevisiae was used as a standard reference for the functional MBL test. Isolates were stored at -80degreesC in 40% glycerol. Before tests were performed, yeast strains were cultured overnight at 35degreesC on Sabouraud Dextrose Agar (SDA) and bacterial strains were cultured overnight at 37degreesC on blood agar and then kept at 4degreesC.
###end p 16
###begin title 17
Binding of MBL
###end title 17
###begin p 18
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 317 318 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 397 400 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 406 409 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 428 430 426 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 576 579 568 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 661 663 652 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 602 607 <span type="species:ncbi:10090">mouse</span>
###xml 865 869 <span type="species:ncbi:9925">goat</span>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
Microorganisms (2 x 107 cells/mL) were incubated with 5 mug/mL of purified human MBL (90%) (HSR 003; Staten Serum Institut; MBL was purified in a two-step process by, affinity chromatography and gel filtration, with selecting for functionally active and oligomeric MBL. MASPs remain associated and co-elute with MBL [6]) in a total volume of 50 muL of veronal-buffered saline pH 7.4, containing Ca2+ and Mg2+ plus 0.05% BSA (VSB2+), on a shaking plate (150 rev/min) at 37degreesC for 30 min. Organisms were spun down for 5 min at 15000 rpm and the pellets were washed with VSB2+ before suspension with mouse anti-MBL monoclonal antibody (mAbs) (10 mug/mL in VSB2+; HYB131-010; Antibody shop, Staten Serum Institute, Copenhagen, Denmark). After a 30-min incubation on ice, samples were centrifuged and washed as described above and were resuspended in FITC-labelled goat anti mouse IgG (DakoCytomation, Glostrup, Denmark) (80 mug/mL in PBS) and incubated on ice for 30 min. Suspensions were centrifuged and washed as described above. Samples were analyzed by flow cytometry (FACSCaliber, Becton Dickinson; Mountain View, CA) with measurement of mean fluorescence intensity (MFI). Experiments were done in duplicate and repeated at least three times. Negative controls were established for MBL binding by the omission of MBL. In order to evaluate whether the binding observed by C-type lectin interactions, inhibition experiments using a calcium chelating agent 20 mmol/L EDTA was added to the MBL solution 5 min before the addition of MBL to the microorganisms.
###end p 18
###begin title 19
Deposition of C4, and C3b
###end title 19
###begin p 20
###xml 282 284 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
MBL-deficient serum was obtained from a subject who was homozygous for the LYPB haplotype of the MBL gene and had undetectable levels of serum MBL (< 0.05 mug/mL). Serum IgG was depleted from the MBL-deficient serum using a HiTrap Protein G column (GE Healthcare, Uppsala, Sweden) [25]. The freshly prepared MBL-deficient serum samples were aliqouted and stored at -70degreesC until use. Informed consent was obtained from the donor.
###end p 20
###begin p 21
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 62 65 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 124 126 123 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 141 142 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 293 295 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 691 697 <span type="species:ncbi:10090">murine</span>
###xml 714 719 <span type="species:ncbi:9606">human</span>
###xml 910 914 <span type="species:ncbi:9925">goat</span>
###xml 920 925 <span type="species:ncbi:10090">mouse</span>
Microorganisms (2 x 106 cells/mL) were incubated in 50 mul HBS2+ (Hepes-buffered saline, 20 mM Hepes, 140 mM NaCl, 5 mM CaCl2 and 2.5 mM MgCl2) containing 10% MBL-deficient serum supplemented with anti-C1q mAb (50 mug/mL; Sanquin, Amsterdam, The Netherlands) to inhibit the classical pathway [26] and with or without purified human MBL (2.5 mug/mL), in a sterile 96 well plate incubated for 2, 5, 15 and 30 minutes at a shaking plate (150 rev/min) at 37degreesC. The reaction in each well was stopped by adding 150 muL of ice-cold PBS. Suspensions were washed and centrifuged for 10 min at 3500 rpm. The supernatants were removed, and the pellets were suspended with 50 muL of a solution of murine monoclonal anti-human C4d (Quidel, San Diego, CA) (4 mug/mL in PBS). After a 30-min incubation on ice, the samples were centrifuged and washed as described above and the pellets were resuspended in FITC-labelled goat anti-mouse IgG (DakoCytomation, Glostrup, Denmark) (80 mug/mL in PBS) and were incubated on ice for 30 min. Suspensions were centrifuged and washed as described above and measured by flow cytometry. C4d deposition was evaluated in duplicate and repeated at least three times.
###end p 21
###begin p 22
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 167 169 167 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 174 179 <span type="species:ncbi:9606">human</span>
C3b deposition was analyzed by incubation of the organisms with 10% MBL-deficient sera in HBS2+, after which surface-bound C3b was detected with FITC-conjugated (Fab')2 anti-human C3 (Protos Immunoresearch, San Francisco, CA) (20 mug/mL in PBS). Detection of C3b deposition was the same as for deposition of C4d.
###end p 22
###begin title 23
Preparation of Polymorphonuclear Leukocytes
###end title 23
###begin p 24
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 701 706 <span type="species:ncbi:9606">human</span>
Human polymorphonuclear (PMN) cells were isolated from the blood of healthy volunteers using a Ficoll/Histopaque gradient with sodium heparin as anticoagulant (Greiner, Alphen a/d Rijn, The Netherlands) as described previously [27]. In brief, heparinized blood was diluted with an equal volume of PBS (pH 7.4), layered onto a gradient of Ficoll-Paque PLUS (GE Healthcare, Uppsala, Sweden) and Histopaque-1119 (Sigma-Aldrich, Steinheim, Germany), and centrifuged for 20 minutes at 400 x g. Neutrophils were collected from the Histopaque layer and washed with RPMI 1640 containing 25 mM Hepes (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), L-glutamine (BioWhittaker, Walkerswille, MD) and 0.05% human serum albumin (Sanquin, Amsterdam, The Netherlands) (RPMI/HSA). The neutrophils were then subjected to a hypotonic shock with water for 30 s to lyse remaining erythrocytes.
###end p 24
###begin title 25
Fluorometric phagocytosis assay
###end title 25
###begin p 26
###xml 133 138 <span type="species:ncbi:9606">human</span>
Phagocytosis was performed using Fluorescein isothiocyanate (FITC)-labelled microorganisms, MBL-deficient serum and freshly isolated human neutrophils. In brief, organisms were mixed (100/100: vol/vol) with FITC (Sigma-Aldrich, Steinheim, Germany) (1 mg/mL in 1 M sodium carbonate buffer, pH 9.6) and incubated at 37degreesC for 1 h under constant shaking at 200 rpm. Organisms were washed with RPMI 1640 medium twice. For each separate experiment, organisms were cultured and labelled with FITC.
###end p 26
###begin p 27
###xml 58 59 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 732 734 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 240 245 <span type="species:ncbi:9606">human</span>
###xml 721 726 <span type="species:ncbi:9606">human</span>
###xml 760 765 <span type="species:ncbi:4932">yeast</span>
###xml 1685 1690 <span type="species:ncbi:9606">human</span>
Aliquots of FITC-labelled microorganisms (50 mul of 2 x 106cells/mL) were transferred in 96-wells microtiter plates. The pellets were tumbled with 20% MBL-deficient serum in the presence of 100 mug/mL anti-C1q mAb, with or without purified human MBL (5 mug/mL, final concentration) and incubated for 15 min on a shaking plate at 37degreesC (150 rev/min). The pellet of the pre-opsonised organisms was suspended in 50 muL of RPMI 1640 and incubated with 50 muL purified PMNs. Phagocytosis was stopped after 15 min by addition of 250 muL ice cold RPMI 1640 and the plate was centrifuged at 4degreesC at 1200 rpm for 10 min. Allophycocyanin (APC)-conjugated CD11b MAb (Becton Dickinson, San Jose, CA) served as a marker for human PMN [28] for the phagocytosis of yeast. The pellet from each well was suspended in 5 muL (250 mug/ml in PBS) and was incubated at 4degreesC for 30 min, followed by the addition of 250 muL of RPMI 1640 to each well and centrifugation at 4degreesC at 1200 rpm for 10 min. The cell pellet was suspended in 250 muL RPMI 1640 supplemented with 1% paraformaldehyde solution (PFA) and stored on ice for 30 min. Analysis of the samples was performed with a flow cytometer. Phagocytosis of the FITC-labelled microorganisms was evaluated by determining the proportion of labelled PMNs expressed as a percentage of the total population of PMNs. The maximum percentages, obtained within an experiment were assigned a value of 100% with all other percentages within the same experiment expressed as a relative percentage of this maximum. Negative controls for opsonophagocytosis were established by incubating organisms in RPMI 1640 containing neither serum nor purified human MBL in the opsonization step.
###end p 27
###begin title 28
Haemolytic MBL assay
###end title 28
###begin p 29
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 303 310 <span type="species:ncbi:9031">chicken</span>
A haemolytic MBL assay was used to study MBL activation by different microorganisms. This assay was previously described by Kuipers et al [3] and makes use of micro-organism-induced MBL activation in a dilution series of pooled human serum, followed by subsequent C5b-6-mediated bystander haemolysis of chicken erythrocytes. As a surplus of all down stream components of the lectin pathway are provided by a standardized concentration of MBL-deficient serum in this assay, the complement activation by bound MBL is the rate limiting step.
###end p 29
###begin p 30
###xml 319 322 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 350 352 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 417 421 415 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-0.5</sup>
###xml 429 432 427 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 616 618 612 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9 </sup>
###xml 645 647 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1221 1223 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1454 1463 1440 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N,N,N',N'</italic>
###xml 1496 1498 1482 1484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1565 1567 1551 1553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 188 193 <span type="species:ncbi:9606">human</span>
###xml 545 552 <span type="species:ncbi:9031">chicken</span>
###xml 618 625 <span type="species:ncbi:9031">chicken</span>
In brief, different microbial concentrations were added in 50 mul per well in a 96 well microtiter plate, and serially diluted in vertical rows (two-fold dilutions). As the source of MBL, human pooled serum (HPS, stored in aliquots as previously described) from healthy workers of our laboratory was diluted 1:32 in VSB2+ and 50 mug/mL anti-C1q mAb [26], incubated on ice for 15 minutes, and then serially diluted (10-0.5) in VSB2+ (final concentration of 1/100 HPS). Samples (50 muL) of each dilution were tested for haemolytic activity, using chicken erythrocytes (50 muL of a mixture of MBL-deficient serum and 109 chicken erythrocytes in VSB2+). The microtiter plates were placed in a water bath at 37degreesC for 1 h and then centrifuged for 10 min, 2500 rpm. Supernatant of each sample was transferred to a flat-bottom plate containing 200 muL Super Q per well. Haemoglobin release was measured in an ELISA reader at 405 nm. Percentages of haemolysis were calculated using controls for 100% (water lysed) and 0% (buffer incubated) haemolysis. After incubation, the degree of bystander erythrocyte lysis was translated into the number of active sites per erythrocyte (Z-value) using the equation of Borsos and Rapp [29]. Titters were read at Z = 0.300. To measure the alternative pathway activation by the different microorganisms, the experiment s described above was performed with HPS in EGTA-VB (8 mM ethylene glycol bis-(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acit with 2.5 mM Mg 2+) preventing classical and lectin pathway activation by removing Ca2+. Direct haemolysis of the erythrocytes by microbial products was excluded by incubating microorganisms and erythrocytes together with MBL-deficient serum only. All experiments were repeated at least three times
###end p 30
###begin title 31
Statistical analysis
###end title 31
###begin p 32
###xml 62 64 62 64 <underline xmlns:xlink="http://www.w3.org/1999/xlink">t </underline>
###xml 62 64 62 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>t </underline></italic>
###xml 157 159 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Statistical significance was determined by unpaired Student's t test, using GraphPad Software program (Prism 5; GraphPad Software, Inc., San Diego, Calif.). P values of < 0.05 were considered to be statistically significant.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
3.1. Binding of MBL to different pathogens
###end title 34
###begin p 35
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 121 132 121 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 134 150 134 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 186 200 186 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 252 261 252 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 263 271 263 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 288 301 288 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 121 132 <span type="species:ncbi:5476">C. albicans</span>
###xml 134 149 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 186 199 <span type="species:ncbi:5207">C. neoformans</span>
###xml 252 261 <span type="species:ncbi:1280">S. aureus</span>
###xml 263 270 <span type="species:ncbi:562">E. coli</span>
###xml 288 301 <span type="species:ncbi:5207">C. neoformans</span>
A striking difference in binding patterns of MBL to the different microorganisms was found (Figure 1). Binding of MBL to C. albicans, C. parapsilosis and in a lesser extend to acapsular C. neoformans was found. Almost no binding of MBL was observed to S. aureus, E. coli and encapsulated C. neoformans. No binding was observed in the absence of Ca2+ (data not shown) and when purified MBL was not added.
###end p 35
###begin p 36
###xml 68 84 68 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 106 117 106 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 119 132 119 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 134 144 134 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 0 155 0 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ca2+-dependent interaction between mannose-binding lectin (MBL) and <italic>C. parapsilosis </italic>and reference strains <italic>C. albicans</italic>, <italic>C. neoformans</italic>, <italic>S. aureus </italic>and <italic>E. coli</italic></bold>
###xml 240 242 239 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 68 83 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 106 117 <span type="species:ncbi:5476">C. albicans</span>
###xml 119 132 <span type="species:ncbi:5207">C. neoformans</span>
###xml 134 143 <span type="species:ncbi:1280">S. aureus</span>
###xml 148 155 <span type="species:ncbi:562">E. coli</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 266 271 <span type="species:ncbi:10090">mouse</span>
###xml 318 322 <span type="species:ncbi:9925">goat</span>
###xml 328 333 <span type="species:ncbi:10090">mouse</span>
###xml 549 554 <span type="species:ncbi:9606">human</span>
###xml 595 600 <span type="species:ncbi:9606">human</span>
Ca2+-dependent interaction between mannose-binding lectin (MBL) and C. parapsilosis and reference strains C. albicans, C. neoformans, S. aureus and E. coli. Microorganisms were incubated in the presence of 5 mug/mL purified human MBL in VSB2+. After incubation with mouse anti-MBL monoclonal antibody and FITC-labeled goat anti mouse IgG, binding of MBL to these microorganisms was analyzed by flow cytometry. Results are expressed as median fluorescence intensity (MFI). Data are the mean +/- SEM of 3 separate experiments. Solid bars, addition of human purified MBL; open bars, no addition of human purified MBL.
###end p 36
###begin title 37
C4 and C3b deposition on the various pathogens
###end title 37
###begin p 38
###xml 5 16 5 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 18 34 18 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 51 65 51 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 243 245 243 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 595 608 595 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 610 620 610 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 624 631 624 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 5 16 <span type="species:ncbi:5476">C. albicans</span>
###xml 18 33 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 51 64 <span type="species:ncbi:5207">C. neoformans</span>
###xml 595 608 <span type="species:ncbi:5207">C. neoformans</span>
###xml 610 619 <span type="species:ncbi:1280">S. aureus</span>
###xml 624 631 <span type="species:ncbi:562">E. coli</span>
With C. albicans, C. parapsilosis and of acapsular C. neoformans deposition of the cleavages product C4 was detected after 2 min of incubation in MBL-deficient serum and was significantly enhanced by the addition of MBL at 2 min up to 10 min (P < 0.005 or P < 0.05, unpaired Student' t test of MFI) (Figure 2). Deposition of C4 was maximal at 5 min, whereas in the absence of MBL C4 deposition attained its maximal amount slowly over the time course measured. In contrast, addition of purified MBL to MBL-deficient serum did not increase C4 deposition significantly to the capsulated strains of C. neoformans, S. aureus and E. coli.
###end p 38
###begin p 39
###xml 32 48 32 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 70 81 70 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 83 96 83 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 98 108 98 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 0 189 0 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Time-dependent C4 deposition on <italic>C. parapsilosis </italic>and reference strains <italic>C. albicans</italic>, <italic>C. neoformans</italic>, <italic>S. aureus </italic>and <italic>E. coli </italic>in MBL-deficient serum supplemented with exogenous purified human MBL</bold>
###xml 447 449 438 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 463 464 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 491 493 482 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 32 47 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 70 81 <span type="species:ncbi:5476">C. albicans</span>
###xml 83 96 <span type="species:ncbi:5207">C. neoformans</span>
###xml 98 107 <span type="species:ncbi:1280">S. aureus</span>
###xml 112 119 <span type="species:ncbi:562">E. coli</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
Time-dependent C4 deposition on C. parapsilosis and reference strains C. albicans, C. neoformans, S. aureus and E. coli in MBL-deficient serum supplemented with exogenous purified human MBL. Microorganisms were incubated with 10% MBL-deficient serum with or without 2.5 mug/mL purified human MBL, at 37degreesC over a time course of 10 min. Results are expressed as median fluorescence (MFI). Data are the mean +/- SEM of 3 separate experiments. *P < 0.05 and ** P< 0.005 unpaired Student's t test of MFI.
###end p 39
###begin p 40
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 208 222 208 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 226 236 226 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 253 261 253 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 280 294 280 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 298 307 298 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 472 484 472 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 485 487 485 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 512 514 512 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 545 560 545 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis</italic>
###xml 572 586 572 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 590 600 590 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 601 603 601 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 614 616 614 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 641 643 641 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 708 721 708 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 761 763 761 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 788 790 788 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 208 221 <span type="species:ncbi:5207">C. neoformans</span>
###xml 226 235 <span type="species:ncbi:1280">S. aureus</span>
###xml 280 293 <span type="species:ncbi:5207">C. neoformans</span>
###xml 298 307 <span type="species:ncbi:1280">S. aureus</span>
###xml 472 483 <span type="species:ncbi:5476">C. albicans</span>
###xml 545 560 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 572 585 <span type="species:ncbi:5207">C. neoformans</span>
###xml 590 599 <span type="species:ncbi:1280">S. aureus</span>
###xml 708 721 <span type="species:ncbi:5207">C. neoformans</span>
Experiments with antibody to C3b (anti-C3b) showed that the addition of purified human MBL enhanced the deposition of C3b on Candida species and, to a lesser degree, C3b deposition on acapsular, encapsulated C. neoformans and S. aureus (Figure 3). With Candida species, acapsular C. neoformans and S. aureus, C3b deposition was detected after 2 min of incubation in serum, with enhancement of deposition in the presence of MBL, reaching significance at 5 up to 30 min for C. albicans (P < 0.05 unpaired Student' t test) and at 15 and 30 min for C. parapsilosis, acapsular C. neoformans and S. aureus (P < 0.005 or P < 0.05 unpaired Student' t test). An increase in C3b deposition was observed for capsulated C. neoformans, reaching significance only at 30 min (P < 0.05 unpaired Student' t test).
###end p 40
###begin p 41
###xml 33 49 33 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 71 82 71 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 84 97 84 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 99 109 99 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 113 121 113 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 0 190 0 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Time-dependent C3b deposition on <italic>C. parapsilosis </italic>and reference strains <italic>C. albicans</italic>, <italic>C. neoformans</italic>, <italic>S. aureus </italic>and <italic>E. coli </italic>in MBL-deficient serum supplemented with exogenous purified human MBL</bold>
###xml 430 432 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 446 447 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 474 476 465 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 33 48 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 71 82 <span type="species:ncbi:5476">C. albicans</span>
###xml 84 97 <span type="species:ncbi:5207">C. neoformans</span>
###xml 99 108 <span type="species:ncbi:1280">S. aureus</span>
###xml 113 120 <span type="species:ncbi:562">E. coli</span>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
Time-dependent C3b deposition on C. parapsilosis and reference strains C. albicans, C. neoformans, S. aureus and E. coli in MBL-deficient serum supplemented with exogenous purified human MBL. Microorganisms were incubated with 10% MBL-deficient serum with or without 2.5 mug/mL purified human MBL, at 37degreesC for 30 min. Results are expressed as median fluorescence (MFI). Data are the mean +/- SEM of 3 separate experiments. *P < 0.05 and ** P< 0.005 unpaired Student's t test of MFI.
###end p 41
###begin title 42
Opsonophagocytosis of different pathogens
###end title 42
###begin p 43
###xml 22 34 22 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 38 54 38 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 226 238 226 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 239 241 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 267 269 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 315 331 315 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 332 334 332 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 360 362 360 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 22 33 <span type="species:ncbi:5476">C. albicans</span>
###xml 38 53 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 226 237 <span type="species:ncbi:5476">C. albicans</span>
###xml 315 330 <span type="species:ncbi:5480">C. parapsilosis</span>
Opsonophagocytosis of C. albicans and C. parapsilosis was enhanced by preincubation in the presence with purified MBL compared to preincubation with MBL-deficient serum alone, reaching significance at 2.5% up to 20% serum for C. albicans (P < 0.05, unpaired Student' t test of % gated) and at 2.5% and 5% serum for C. parapsilosis (P < 0.05, unpaired Student' t test of % gated) (Figure 4).
###end p 43
###begin p 44
###xml 22 38 22 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 60 71 60 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 73 86 73 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 88 98 88 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 0 148 0 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Opsonophagocytosis of <italic>C. parapsilosis </italic>and reference strains <italic>C. albicans</italic>, <italic>C. neoformans</italic>, <italic>S. aureus </italic>and <italic>E. coli </italic>by human polymorphonuclear (PMN) cells</bold>
###xml 587 589 584 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 603 604 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 631 633 628 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 22 37 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 60 71 <span type="species:ncbi:5476">C. albicans</span>
###xml 73 86 <span type="species:ncbi:5207">C. neoformans</span>
###xml 88 97 <span type="species:ncbi:1280">S. aureus</span>
###xml 102 109 <span type="species:ncbi:562">E. coli</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 351 356 <span type="species:ncbi:9606">human</span>
###xml 387 392 <span type="species:ncbi:4932">yeast</span>
Opsonophagocytosis of C. parapsilosis and reference strains C. albicans, C. neoformans, S. aureus and E. coli by human polymorphonuclear (PMN) cells. Microorganisms were labelled with fluorescein isothiocyanate (FITC) and preincubated in the absence (control) or presence of 20% mannose-binding lectin (MBL)-deficient serum supplemented with 5 mug/mL human purified MBL, for 20 min. The yeast:phagocyte ratio was 2:1. Phagocytosis was analyzed by the use of flow cytometry and expressed as percentage of microorganisms-ingested PMN. Data are the mean +/- SEM of 3 separate experiments. *P < 0.05 and ** P< 0.005 unpaired Student's t test of phagocytosis % gated.
###end p 44
###begin p 45
###xml 101 115 101 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 127 138 127 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida spp</italic>
###xml 197 199 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 225 227 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 270 284 270 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 356 366 356 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 370 378 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 586 596 586 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 597 599 597 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 626 628 626 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 101 114 <span type="species:ncbi:5207">C. neoformans</span>
###xml 270 283 <span type="species:ncbi:5207">C. neoformans</span>
###xml 345 350 <span type="species:ncbi:9606">human</span>
###xml 356 365 <span type="species:ncbi:1280">S. aureus</span>
###xml 370 377 <span type="species:ncbi:562">E. coli</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
###xml 586 595 <span type="species:ncbi:1280">S. aureus</span>
We noted less opsonophagocytosis in the presence with purified human MBL and the acapsular strain of C. neoformans compared to Candida spp., although significance was reached at 10% and 20% serum (P < 0.05, unpaired Student' t test of % gated). The capsulated strain of C. neoformans showed no opsonophagocytosis with or without adding purified human MBL. S. aureus and E. coli showed no opsonophagocytosis in the lowest concentration with or without adding purified human MBL. But MBL appears to play a role in the higher serum concentrations, reaching a significance at 20% serum for S. aureus (P < 0.005, unpaired Student' t test of % gated). When downstream complement components were inactivated by heating at 56degreesC, opsonophagocytosis was eliminated under all conditions tested (data not shown).
###end p 45
###begin title 46
Haemolytic assessment of complement activity via the lectin pathway
###end title 46
###begin p 47
###xml 541 554 541 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 556 567 556 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 569 584 569 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis</italic>
###xml 624 638 624 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 642 652 642 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 656 664 656 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 671 672 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 679 693 679 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 702 712 702 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 721 729 721 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 541 554 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 556 567 <span type="species:ncbi:5476">C. albicans</span>
###xml 569 584 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 624 637 <span type="species:ncbi:5207">C. neoformans</span>
###xml 642 651 <span type="species:ncbi:1280">S. aureus</span>
###xml 656 663 <span type="species:ncbi:562">E. coli</span>
###xml 679 692 <span type="species:ncbi:5207">C. neoformans</span>
###xml 702 711 <span type="species:ncbi:1280">S. aureus</span>
###xml 721 728 <span type="species:ncbi:562">E. coli</span>
The haemolytic assay was used to characterize the different microorganisms as a weak or potent activator of the MBL arm of the complement system at a 1/32 dilution of HPS, since no activation of the alternative pathway was observed with this dilution (data not shown). In this assay, the number of microbes and the MBL concentration were varied. Addition of the inhibitory antibody directed against C1q eliminated the contribution of the classical pathway. The following organisms were ranked, in order of decreasing MBL-activating ability, S. cerevisiae, C. albicans, C. parapsilosis, encapsulated, and acapsular strain of C. neoformans and S. aureus and E. coli (Table 1). The C. neoformans strains, S. aureus strains, E. coli strains did not activate MBL at this serum concentration.
###end p 47
###begin p 48
###xml 53 66 53 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 68 79 68 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 81 96 81 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis</italic>
###xml 98 111 98 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 113 121 113 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 125 135 125 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 53 66 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 68 79 <span type="species:ncbi:5476">C. albicans</span>
###xml 81 96 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 98 111 <span type="species:ncbi:5207">C. neoformans</span>
###xml 113 120 <span type="species:ncbi:562">E. coli</span>
###xml 125 134 <span type="species:ncbi:1280">S. aureus</span>
Differential lectin pathway activating properties of S. cerevisiae, C. albicans, C. parapsilosis, C. neoformans, E. coli and S. aureus via MBL
###end p 48
###begin p 49
###xml 126 133 <span type="species:ncbi:9031">chicken</span>
Z value stands for the amount of haemolysis in the haemolytic assay, a measure of the mean number of MBL activating sites per chicken erythrocyte. CFU: Colony-forming units
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 329 345 329 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 353 364 353 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 375 385 375 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 389 403 389 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 455 470 455 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis</italic>
###xml 472 484 472 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 498 511 498 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 724 732 724 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 754 767 754 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 838 851 838 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 936 946 936 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 950 957 950 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E coli </italic>
###xml 1001 1010 1001 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 1012 1020 1012 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1024 1038 1024 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1474 1482 1474 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 1504 1517 1504 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 329 344 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 353 364 <span type="species:ncbi:5476">C. albicans</span>
###xml 366 373 <span type="species:ncbi:562">E. coli</span>
###xml 375 384 <span type="species:ncbi:1280">S. aureus</span>
###xml 389 402 <span type="species:ncbi:5207">C. neoformans</span>
###xml 455 470 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 472 483 <span type="species:ncbi:5476">C. albicans</span>
###xml 498 511 <span type="species:ncbi:5207">C. neoformans</span>
###xml 754 767 <span type="species:ncbi:5207">C. neoformans</span>
###xml 838 851 <span type="species:ncbi:5207">C. neoformans</span>
###xml 936 945 <span type="species:ncbi:1280">S. aureus</span>
###xml 1001 1010 <span type="species:ncbi:1280">S. aureus</span>
###xml 1012 1019 <span type="species:ncbi:562">E. coli</span>
###xml 1024 1037 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1323 1328 <span type="species:ncbi:4932">yeast</span>
###xml 1504 1517 <span type="species:ncbi:5207">C. neoformans</span>
Mannose binding lectin (MBL), is a calcium-dependent plasma lectin that binds a wide range of microorganisms [5]. In the present study, we evaluated the role of binding of MBL at the subsequent deposition of C4 and C3b on the microbial cell wall. Also the role of MBL in opsonophagocytosis by PMN was studied. Well-characterized C. parapsilosis strain, C. albicans, E. coli, S. aureus and C. neoformans were used. These data demonstrate that MBL binds to C. parapsilosis, C. albicans and acapsular C. neoformans. MBL binding leads to activation of the lectin pathway of complement, demonstrated by deposition of C4 and C3 fragments and to enhanced opsonophagocytosis by PMNs. MBL is an important opsonin for phagocytosis of Candida species and acapsular C. neoformans. It lacks the function as an opsonin for phagocytosis of encapsulated C. neoformans. Indeed, MBL plays a much less important role in the process of opsonisation of the S. aureus and E coli strains used. The lack of MBL activation of S. aureus, E. coli and C. neoformans could be advantageous to the organism in allowing it to remain hidden from the MBL arm of the complement system (i.e., protected from lectin pathway-induced complement activation). Serum MBL levels would be unlikely to influence these organisms colonization/infection, compared to the yeast, which are strong activators of the MBL arm of the complement system. These data suggest the importance of MBL in the first-line defence against Candida species and acapsular C. neoformans.
###end p 51
###begin p 52
###xml 67 79 67 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 83 99 83 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 126 139 126 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 281 290 281 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 292 300 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 317 331 317 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 362 376 362 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 407 415 407 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 489 501 489 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 67 78 <span type="species:ncbi:5476">C. albicans</span>
###xml 83 98 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 126 139 <span type="species:ncbi:5207">C. neoformans</span>
###xml 281 290 <span type="species:ncbi:1280">S. aureus</span>
###xml 292 299 <span type="species:ncbi:562">E. coli</span>
###xml 317 330 <span type="species:ncbi:5207">C. neoformans</span>
###xml 362 375 <span type="species:ncbi:5207">C. neoformans</span>
###xml 489 500 <span type="species:ncbi:5476">C. albicans</span>
Previously, studies have shown that MBL binds with high avidity to C. albicans and C. parapsilosis as well as to encapsulated C. neoformans, through mannan, a major component of fungal cell walls [4,30,31]. Microorganisms, as observed in the present study, fall into three groups. S. aureus, E. coli and encapsulated C. neoformans did not bind to MBL, acapsular C. neoformans bound MBL only weakly and both Candida species showed strong MBL binding. MBL has recently been shown to bind to C. albicans via its lectin domain, resulting in fungi agglutination on their hyphea outgrowths [9].
###end p 52
###begin p 53
###xml 56 64 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 163 177 163 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 163 176 <span type="species:ncbi:5207">C. neoformans</span>
Capsules have an important role in protecting organisms in vivo against complement attack, by making them resistant to phagocytosis [13,32]. The acapsular form of C. neoformans has exposed carbohydrate residues on its surface that are suitable for interaction with lectin-like receptors [30]. Thus, the levels of MBL required for opsonophagocytosis may depend on the availability of binding epitopes on the infectious agents.
###end p 53
###begin p 54
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 228 257 228 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans, C. parapsilosis </italic>
###xml 270 284 270 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 228 239 <span type="species:ncbi:5476">C. albicans</span>
###xml 241 256 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 270 283 <span type="species:ncbi:5207">C. neoformans</span>
The opsonophagocytosis assay and the complement-deficient sera used in these experiments allowed us to measure MBL dependent opsonization, because the classical pathway was blocked with anti-C1q [7]. MBL increased the uptake of C. albicans, C. parapsilosis andacapsular C. neoformans by PMNs in serum. Since phagocytosis was not observed by binding of MBL in the absence of down-stream complement factors (data not shown), phagocytosis was enhanced via C3b-dependent opsonization recognized by complement receptors on PMNs. Thus, MBL is an opsonin only in the presence of complement.
###end p 54
###begin p 55
###xml 40 41 40 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 194 206 194 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 390 400 390 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 524 534 524 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 647 649 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 851 852 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 886 893 882 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1015 1017 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1018 1020 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1049 1051 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1092 1105 1088 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 1107 1117 1103 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 1121 1128 1117 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1271 1273 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 194 205 <span type="species:ncbi:5476">C. albicans</span>
###xml 390 399 <span type="species:ncbi:1280">S. aureus</span>
###xml 524 533 <span type="species:ncbi:1280">S. aureus</span>
###xml 886 893 <span type="species:ncbi:562">E. coli</span>
###xml 1092 1105 <span type="species:ncbi:2104|species:ncbi:1313">S. pneumoniae</span>
###xml 1107 1116 <span type="species:ncbi:1280">S. aureus</span>
###xml 1121 1128 <span type="species:ncbi:562">E. coli</span>
In contrast to our results, Ip and Lau [9], using dendritic cells, reported that MBL binding does not lead to opsonophagocytosis, possibly due to the interference of MBL with the recognition of C. albicans by C-type receptors on dendritic cells, which mediate phagocytosis. Neth et al. [33] demonstrated that an MBL-mediated increases in opsonic C3 fragments enhanced opsonophagocytosis of S. aureus by neutrophils. However, Cunnion et al. [34] showed similar to us, that MBL-mediated complement activation, did not enhance S. aureus phagocytosis. They used hypo-gamma-globulin serum, which had been affinity-depleted of MBL, whereas Neth et al. [33] used serum from adult individuals who were genetically deficient in MBL, but which could contain immunoglobulins. Bacterial strain differences could account for the differences find in these reports [4]. Comparable to our results with E. coli, previous experiments also have shown that MBL contributed little to opsonophagocytosis of gram-negative microorganisms [35-37]. Recently, Brouwer et al. [38] reported MBL binding on the surface of S. pneumoniae, S. aureus and E. coli, but did not observe any significant contribution of MBL to opsonophagocytosis of these organisms. Comparable to our results, Brouwer et al. [38] indicates that the lectin pathway of complement activation did not contribute to a large extent of the opsonophagocytosis of these bacteria.
###end p 55
###begin p 56
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 283 293 283 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 401 410 401 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 453 463 453 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 546 555 546 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 30 45 <span type="species:ncbi:10090">transgenic mice</span>
###xml 283 292 <span type="species:ncbi:1280">S. aureus</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">Mice</span>
###xml 401 410 <span type="species:ncbi:1280">S. aureus</span>
###xml 453 462 <span type="species:ncbi:1280">S. aureus</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
Also it was shown that in MBL transgenic mice MBL plays an important role in the innate immunity [39]. In contrast to our observations, Shi et al. [40] reported that MBL-initiated opsonophagocytosis by both neutrophils and macrophages is an important first-line host defence against S. aureus in mice. Mice that do not have a functional MBL complement pathway are highly susceptible to infection with S. aureus. In that study, decreased phagocytosis of S. aureus by peritoneal macrophages in MBL-null mice was reported [40]. However, we only did in vitro studies, which may or may not explain the susceptibilities of MBL deficient individuals to these organisms. Further studies are needed to define the role of MBL in the defence against these bacteria.
###end p 56
###begin p 57
###xml 31 53 31 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neisseria meningitidis</italic>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 31 53 <span type="species:ncbi:487">Neisseria meningitidis</span>
Previously, it has shown, that Neisseria meningitidis, the causative agent of meningococcal disease, is a strong activator of MBL [3]. This is in line with clinical studies, which showed that MBL is associated with an increased risk of mucosal acquired infections including meningococcal disease [41]. However, the role of MBL as an opsonin may thus critically depend on the microbial species involved, interspecies variation and the type of phagocytes present.
###end p 57
###begin p 58
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 231 243 231 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 247 263 247 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 190 195 <span type="species:ncbi:4932">yeast</span>
###xml 231 242 <span type="species:ncbi:5476">C. albicans</span>
###xml 247 262 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 302 310 <span type="species:ncbi:9606">patients</span>
###xml 334 339 <span type="species:ncbi:4932">yeast</span>
###xml 379 384 <span type="species:ncbi:4932">yeast</span>
###xml 399 406 <span type="species:ncbi:9606">patient</span>
A number of clinical studies have reported that MBL deficiency predisposes to Candida infections. Recently, Till et al. [42] described that patients with peritonitis with an early abdominal yeast infection, most commonly caused by C. albicans and C. parapsilosis [43], had lower MBL plasma levels than patients without such abdominal yeast infections. The incidence of abdominal yeast infections in patient with MBL variant genotype was significantly higher to those with no MBL variant genotype [42].
###end p 58
###begin p 59
###xml 85 97 85 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 208 216 208 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 336 344 336 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 712 728 712 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 85 96 <span type="species:ncbi:5476">C. albicans</span>
###xml 261 269 <span type="species:ncbi:9606">patients</span>
###xml 712 727 <span type="species:ncbi:5480">C. parapsilosis</span>
MBL present in the vaginal cavity has been found to act as recognition molecules for C. albicans that colonize the cervicovaginal mucosa, which suggest that the lectin pathway plays an important role against Candida infection [44]. Low levels of vaginal MBL in patients with recurrent vulvovaginal candidiasis (VVC) might predispose to Candida infections [45]. It has been proposed that MBL activity is critical in early life, when maternally acquired protection is decreasing and actively acquired immunity is still low [5,39,46]. MBL plasma concentrations at birth may be low due to both gene-polymorphisms and younger gestational age [47-49]. Thus MBL activity may play an important role in innate defence of C. parapsilosis in premature babies.
###end p 59
###begin title 60
Conclusion
###end title 60
###begin p 61
###xml 128 157 128 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis, C. albicans </italic>
###xml 171 184 171 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 215 230 215 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis</italic>
###xml 232 244 232 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 258 271 258 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 128 143 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 145 156 <span type="species:ncbi:5476">C. albicans</span>
###xml 171 184 <span type="species:ncbi:5207">C. neoformans</span>
###xml 215 230 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 232 243 <span type="species:ncbi:5476">C. albicans</span>
###xml 258 271 <span type="species:ncbi:5207">C. neoformans</span>
###xml 397 403 <span type="species:ncbi:4932">yeasts</span>
In conclusion, the present study demonstrated the important role of MBL-mediated complement activation in opsonophagocytosis of C. parapsilosis, C. albicans and acapsular C. neoformans. MBL enhances opsonization of C. parapsilosis, C. albicans and acapsular C. neoformans, via the lectin pathway, which depends on the presence and availability of MBL binding epitopes. The binding of MBL by these yeasts and subsequent complement activation and opsonophagocytosis observed in our study may explain the observed increased risk of infections caused by these microorganisms in MBL-deficient individuals.
###end p 61
###begin title 62
Authors' contributions
###end title 62
###begin p 63
AE participated in the design of the study, carried out the experiments and drafted the manuscript; HA participated in the design of the study and coordination; SJ carried out the experiment; HB participated in the design of the haemolytic assay; VJ conceived of the study, participated in its design and coordination. All authors read and approved the final manuscript.
###end p 63
###begin title 64
Acknowledgements
###end title 64
###begin p 65
###xml 273 289 273 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. parapsilosis </italic>
###xml 273 288 <span type="species:ncbi:5480">C. parapsilosis</span>
###xml 343 350 <span type="species:ncbi:9031">chicken</span>
The authors thank David Stevens (Division of Infectious Diseases, Santa Clara Valley Medical Centre, and California Institute for Medical Research, San Jose, and Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA) for providing C. parapsilosis isolates, Roel Terluin (Wageningen) for providing the chicken erythrocytes and Piet Aerts (Eijkman-Winkler Institute for Medical & Clinical Microbiology and, Utrecht University Hospital).
###end p 65
###begin article-title 66
Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop
###end article-title 66
###begin article-title 67
Role of the mannose-binding lectin in innate immunity
###end article-title 67
###begin article-title 68
Differential microorganism-induced mannose-binding lectin activation
###end article-title 68
###begin article-title 69
Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition
###end article-title 69
###begin article-title 70
The role of mannose-binding lectin in health and disease
###end article-title 70
###begin article-title 71
###xml 44 49 <span type="species:ncbi:9606">human</span>
Mannan-binding lectin (MBL) production from human plasma
###end article-title 71
###begin article-title 72
New perspectives on mannan-binding lectin-mediated complement activation
###end article-title 72
###begin article-title 73
Anti-microbial activities of mannose-binding lectin
###end article-title 73
###begin article-title 74
###xml 61 77 61 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 61 77 <span type="species:ncbi:5476">Candida albicans</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells
###end article-title 74
###begin article-title 75
Mannose-binding lectin in innate immunity: past, present and future
###end article-title 75
###begin article-title 76
The lectin pathway of complement activation
###end article-title 76
###begin article-title 77
Mannose-binding lectin: structure, function, genetics and disease associations
###end article-title 77
###begin article-title 78
###xml 69 93 69 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 69 81 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 69 92 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Binding of Serum Mannan Binding Lectin to a Cell Integrity-Defective Cryptococcus neoformans ccr4{Delta} Mutant
###end article-title 78
###begin article-title 79
Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation
###end article-title 79
###begin article-title 80
Impact of mannose-binding lectin on susceptibility to infectious diseases
###end article-title 80
###begin article-title 81
###xml 61 69 61 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 231 242 <span type="species:ncbi:9606">Participant</span>
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe)
###end article-title 81
###begin article-title 82
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998
###end article-title 82
###begin article-title 83
Epidemiology of candidemia
###end article-title 83
###begin article-title 84
###xml 41 62 41 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida parapsilosis </italic>
###xml 41 61 <span type="species:ncbi:5480">Candida parapsilosis</span>
Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit
###end article-title 84
###begin article-title 85
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida parapsilosis </italic>
###xml 0 20 <span type="species:ncbi:5480">Candida parapsilosis</span>
Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers
###end article-title 85
###begin article-title 86
###xml 13 34 13 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida parapsilosis </italic>
###xml 13 33 <span type="species:ncbi:5480">Candida parapsilosis</span>
###xml 83 91 <span type="species:ncbi:9606">children</span>
Emergence of Candida parapsilosis as the predominant species causing candidemia in children
###end article-title 86
###begin article-title 87
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida parapsilosis </italic>
###xml 0 20 <span type="species:ncbi:5480">Candida parapsilosis</span>
Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers
###end article-title 87
###begin article-title 88
###xml 4 21 4 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">albicans Candida </italic>
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
###end article-title 88
###begin article-title 89
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice
###end article-title 89
###begin article-title 90
Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans
###end article-title 90
###begin article-title 91
Evidence that complement protein C1q interacts with C-reactive protein through its globular head region
###end article-title 91
###begin article-title 92
Dual effects of soluble CD14 on LPS priming of neutrophils
###end article-title 92
###begin article-title 93
###xml 38 55 38 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 38 54 <span type="species:ncbi:5476">Candida albicans</span>
Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils
###end article-title 93
###begin article-title 94
Chromatographic Separation of the First Component of Complement and Its Assay on a Molecular Basis
###end article-title 94
###begin article-title 95
###xml 23 47 23 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 23 35 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 23 46 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form
###end article-title 95
###begin article-title 96
###xml 152 175 152 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans</italic>
###xml 99 120 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 152 164 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 152 175 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans
###end article-title 96
###begin article-title 97
###xml 11 35 11 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 11 23 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 11 34 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
What makes Cryptococcus neoformans a pathogen?
###end article-title 97
###begin article-title 98
###xml 171 192 171 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 171 192 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus
###end article-title 98
###begin article-title 99
###xml 36 58 36 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 36 57 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis
###end article-title 99
###begin article-title 100
###xml 49 53 <span type="species:ncbi:10090">mice</span>
LPS-induced platelet response and rapid shock in mice: contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system
###end article-title 100
###begin article-title 101
Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2
###end article-title 101
###begin article-title 102
###xml 92 108 92 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 92 108 <span type="species:ncbi:562">Escherichia coli</span>
The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli
###end article-title 102
###begin article-title 103
###xml 63 69 <span type="species:ncbi:4932">yeasts</span>
Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding
###end article-title 103
###begin article-title 104
###xml 78 93 <span type="species:ncbi:10090">transgenic mice</span>
Mannose binding protein is involved in first-line host defence: evidence from transgenic mice
###end article-title 104
###begin article-title 105
###xml 72 93 72 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 72 93 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus
###end article-title 105
###begin article-title 106
###xml 60 83 60 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neisseria meningitidis </italic>
###xml 60 82 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages
###end article-title 106
###begin article-title 107
###xml 56 64 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Mannose-binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis
###end article-title 107
###begin article-title 108
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida parapsilosis </italic>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 0 20 <span type="species:ncbi:5480">Candida parapsilosis</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis patients
###end article-title 108
###begin article-title 109
Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina
###end article-title 109
###begin article-title 110
Mannose-binding lectin and vulvovaginal candidiasis
###end article-title 110
###begin article-title 111
Mannose-binding lectin: the pluripotent molecule of the innate immune system
###end article-title 111
###begin article-title 112
###xml 35 42 <span type="species:ncbi:9606">infants</span>
Mannose-binding protein in preterm infants: developmental profile and clinical significance
###end article-title 112
###begin article-title 113
Host defence lectins in preterm neonates
###end article-title 113
###begin article-title 114
High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates
###end article-title 114

